Genscript Biotech share increases by 0.37 % and records a trading volume of 112.7 million HKD in the last 24 hours

Genscript Biotech share increases by 0.37 % and records a trading volume of 112.7 million HKD in the last 24 hours

Genscript Biotech has had an increase of 0.37% in the last 24 hours and can currently be bought for around 18.56 HKD. The company has a market capitalization of 34.7 billion HKD and a current offer of 2.1 billion Genscript Biotech shares. In the last 24 hours, shares worth around 112.7 million HKD have been traded. Since the end of the last month, the share price has dropped by -6.48%. The simple moving average of the last 200 days is 20.58 HKD. The highest price of the share in the last 52 weeks was reached on August 5, 2022 at 31.25 HKD, while the low on October 12, 2022 was 13.96 HKD.

In terms of related shares, there have been various developments in the past 24 hours. Hansoh Pharmaceutical fell by -0.48% and is currently traded at 12.38 HKD. The company's market capitalization is 76.3 billion HKD, while the price-profit ratio is 25.68. 3D Medicines fell by -38.27% and is currently being traded at 52.2 HKD, with a capitalization of 26.9 billion HKD. China Pharmaceutical fell by -1.49% and is now traded at 5.9 HKD, with a current market capitalization of 39.5 billion HKD and a price-profit ratio of 9.46.

An article entitled "Buy, hold or sell Genscript Biotech?" Valid that investors should read the current GenScript biotech analysis to find out how the company will develop and whether an entry or a sale is recommended. The article contains a link to analysis.